Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
2024 · Molecular Cancer · 87 citations
https://doi.org/10.1186/s12943-024-02108-6
J
Jian Liang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
2.0K
Citations
28
h-index
49
i10-index
Jian Liang is an academic researcher from Jiangxi University of Traditional Chinese Medicine. The author has contributed to research in topics: Retinal Diseases and Treatments & Liver Disease Diagnosis and Treatment & MicroRNA in disease regulation. The author has an h-index of 28, co-authored 78 publications.
ORCID: 0000-0002-6027-0278Papers by this author
worksEsculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway
2024 · Phytomedicine · 66 citations
https://doi.org/10.1016/j.phymed.2024.155465
Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model
2019 · Biomedicine & Pharmacotherapy · 61 citations
https://doi.org/10.1016/j.biopha.2019.109683
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy
2022 · Science Translational Medicine · 58 citations
https://doi.org/10.1126/scitranslmed.abj2177
Photosensitization of A2E triggers telomere dysfunction and accelerates retinal pigment epithelium senescence
2018 · Cell Death and Disease · 51 citations
https://doi.org/10.1038/s41419-017-0200-7
PINK1/Parkin pathway-mediated mitophagy by AS-IV to explore the molecular mechanism of muscle cell damage
2023 · Biomedicine & Pharmacotherapy · 19 citations
https://doi.org/10.1016/j.biopha.2023.114533
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat